Patient Characteristics and Previous Therapies
| Parameter | Data |
|---|---|
| Age (y) | |
| Mean ± SD | 67.5 ± 8 |
| Range | 52–84 |
| Serum prostate-specific antigen (ng/mL) | |
| Mean ± SD | 401 ± 1,353 |
| Range | 0.098–9,235.13 |
| Gleason score | |
| Group 1 | 1 |
| Group 2 | 6 |
| Group 3 | 9 |
| Group 4 | 17 |
| Group 5 | 17 |
| Surgery (prostatectomy ± orchidectomy) (n) | |
| Yes | 50 (100%) |
| No | 0 (0%) |
| Hormonal treatment (n) | |
| Yes | 46 (92%) |
| No | 4 (8%) |
| Chemotherapy (n) | |
| Yes | 39 (78%) |
| No | 11 (22%) |
| External-beam radiation therapy (n) | |
| Yes | 24 (48%) |
| No | 26 (52%) |
| 177Lu-PSMA therapy (n) | |
| Yes | 16 (32%) |
| No | 34 (68%) |
| Initial staging (n) | |
| Yes | 11 (22%) |
| No | 39 (78%) |
| Restaging (n) | |
| Yes | 45 (90%) |
| No | 5 (10%) |